Related Experiment Video
Updated: Mar 12, 2026

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
1.3K
Opportunities and Challenges in Implementing Large Language Models (LLMs) in Oncology.
JCO Clinical Cancer Informatics
|March 10, 2026
Summary
Large language models (LLMs) offer significant advancements in cancer care, from clinical insights to research acceleration. However, careful consideration of ethical concerns and implementation challenges is crucial for responsible integration.
Area of Science:
- Oncology
- Artificial Intelligence
- Bioinformatics
Background:
- Large language models (LLMs) and artificial intelligence (AI) are poised to transform cancer care.
- Their integration presents both significant opportunities and challenges in clinical and translational oncology.
Purpose of the Study:
- To explore the potential of LLMs and AI in revolutionizing cancer care.
- To identify the opportunities and challenges associated with their implementation in oncology.
Main Methods:
- Analysis of LLM applications in clinical oncology (pathology, radiology, genomics).
- Evaluation of LLM roles in translational research (single-cell transcriptomics, spatial omics, computational pathology).
- Review of ethical considerations (trust, equity, privacy, transparency, non-maleficence, accountability) and implementation hurdles (hallucination, cost, disparities, regulation).
Main Results:
- LLMs can extract large-scale insights from clinical data and accelerate translational research for precision oncology.
- Ethical concerns and implementation challenges, including hallucination risks and healthcare disparities, require careful management.
- Navigating a complex regulatory landscape is essential for responsible deployment.
Conclusions:
- LLMs and AI hold immense promise for advancing cancer care and research.
- Responsible implementation necessitates rigorous validation, ethical vigilance, and a focus on patient welfare.
- Addressing challenges is key to realizing the full potential of AI in oncology.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Improving Translational Accuracy
15.3K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.3K
Improving Translational Accuracy
3.7K
3.7K

